Lincoln National Corp Has $2.79 Million Position in CVS Health Co. (NYSE:CVS)

Lincoln National Corp boosted its stake in shares of CVS Health Co. (NYSE:CVSGet Rating) by 1.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,581 shares of the pharmacy operator’s stock after acquiring an additional 328 shares during the quarter. Lincoln National Corp’s holdings in CVS Health were worth $2,791,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. West Bancorporation Inc. bought a new stake in shares of CVS Health during the fourth quarter worth $25,000. Macroview Investment Management LLC grew its holdings in shares of CVS Health by 128.3% during the first quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 136 shares during the last quarter. Claremont Financial Group Inc. bought a new stake in shares of CVS Health during the fourth quarter worth $26,000. Stuart Chaussee & Associates Inc. grew its holdings in shares of CVS Health by 123.0% during the first quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 171 shares during the last quarter. Finally, Capital Advisors Ltd. LLC grew its holdings in shares of CVS Health by 125.7% during the fourth quarter. Capital Advisors Ltd. LLC now owns 316 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 176 shares during the last quarter. Institutional investors own 78.00% of the company’s stock.

CVS Health Trading Up 0.4 %

NYSE CVS opened at $102.26 on Friday. The firm has a market cap of $134.25 billion, a P/E ratio of 16.63, a P/E/G ratio of 1.55 and a beta of 0.75. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.91 and a quick ratio of 0.62. The stock’s 50-day moving average is $94.36 and its 200-day moving average is $99.93. CVS Health Co. has a one year low of $80.15 and a one year high of $111.25.

CVS Health (NYSE:CVSGet Rating) last released its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $2.16 by $0.24. The company had revenue of $80.64 billion for the quarter, compared to analyst estimates of $76.38 billion. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. CVS Health’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.42 earnings per share. Sell-side analysts anticipate that CVS Health Co. will post 8.54 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 1st. Investors of record on Friday, July 22nd were given a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date was Thursday, July 21st. CVS Health’s dividend payout ratio is presently 35.77%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CVS. Deutsche Bank Aktiengesellschaft increased their target price on CVS Health from $113.00 to $120.00 in a report on Thursday. UBS Group raised their price target on CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a report on Thursday. Sanford C. Bernstein cut CVS Health from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $122.00 to $112.00 in a report on Thursday, May 26th. Finally, Loop Capital assumed coverage on CVS Health in a report on Thursday, June 16th. They issued a “buy” rating and a $120.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $116.90.

Insider Activity at CVS Health

In related news, EVP Thomas M. Moriarty sold 138,654 shares of CVS Health stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the sale, the executive vice president now owns 626,273 shares of the company’s stock, valued at approximately $59,495,935. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, EVP Thomas M. Moriarty sold 138,654 shares of CVS Health stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the sale, the executive vice president now owns 626,273 shares of the company’s stock, valued at approximately $59,495,935. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total value of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.

CVS Health Company Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Further Reading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.